![]() |
Volumn 18, Issue 6, 2003, Pages 1160-1162
|
Osteoporosis Panel Summary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
PLACEBO;
ALTRUISM;
BONE DENSITY;
BONE MINERAL;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE MARKER;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG USE;
FEMALE;
FRAGILITY FRACTURE;
HUMAN;
INFORMED CONSENT;
MALE;
MEDICAL ETHICS;
METHODOLOGY;
OSTEOPOROSIS;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
RISK BENEFIT ANALYSIS;
WORLD HEALTH ORGANIZATION;
CLINICAL TRIALS;
CONTROLLED CLINICAL TRIALS;
DRUG INDUSTRY;
HUMANS;
OSTEOPOROSIS;
PLACEBOS;
RISK ASSESSMENT;
UNITED STATES;
|
EID: 0142027573
PISSN: 08840431
EISSN: None
Source Type: Journal
DOI: 10.1359/jbmr.2003.18.6.1160 Document Type: Conference Paper |
Times cited : (5)
|
References (0)
|